Article
Systemic interleukin signaling and Alzheimer's disease risk: A two-sample cross-replication Mendelian randomization study.
Journal of Alzheimer's disease : JAD - 1 Jul 2026
Ahmed Hafiz M, Ali Siddique M, Shaheer Ul Islam M, Khan Lodhi Abdul Rafay, Owais Muhammad, Rehman Ubaid Ur
Abstract excerpt
BackgroundAlzheimer's disease (AD) is the leading cause of dementia worldwide, yet no disease-modifying therapy exists. Systemic inflammation has been proposed as a causal factor, supported by observational studies reporting elevated plasma interleukins in AD, though such studies cannot establish causality. Recent evidence instead highlights local neuroinflammation and microglial dysfunction as key...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
